Free Trial

111 Capital Invests $301,000 in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

111 Capital acquired a new position in shares of Genpact Limited (NYSE:G - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 7,015 shares of the business services provider's stock, valued at approximately $301,000.

Other large investors have also modified their holdings of the company. Coppell Advisory Solutions LLC lifted its holdings in shares of Genpact by 529.5% during the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after acquiring an additional 503 shares during the period. SRH Advisors LLC purchased a new position in shares of Genpact during the 4th quarter worth about $26,000. Atlas Capital Advisors Inc. raised its holdings in Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after buying an additional 216 shares during the period. GeoWealth Management LLC raised its holdings in Genpact by 199.0% in the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after buying an additional 583 shares during the period. Finally, Manchester Capital Management LLC purchased a new position in Genpact in the fourth quarter valued at approximately $38,000. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. This trade represents a 4.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Nicholas C. Gangestad purchased 2,000 shares of the firm's stock in a transaction dated Tuesday, May 13th. The shares were bought at an average cost of $43.97 per share, with a total value of $87,940.00. Following the transaction, the director now directly owns 2,000 shares of the company's stock, valued at approximately $87,940. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. 3.07% of the stock is owned by corporate insiders.

Genpact Stock Up 0.0%

NYSE:G traded up $0.01 during trading hours on Tuesday, hitting $42.76. The stock had a trading volume of 1,283,686 shares, compared to its average volume of 1,373,113. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 1-year low of $30.38 and a 1-year high of $56.76. The business has a 50 day simple moving average of $46.44 and a two-hundred day simple moving average of $47.27. The company has a market cap of $7.48 billion, a PE ratio of 15.06, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.04. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The company had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same quarter last year, the company earned $0.73 earnings per share. Genpact's revenue for the quarter was up 7.4% on a year-over-year basis. Analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Analyst Ratings Changes

Several research firms recently commented on G. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and raised their price target for the company from $45.00 to $60.00 in a report on Friday, February 7th. Mizuho raised their price target on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC cut their price target on shares of Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, May 8th. Finally, Robert W. Baird cut their price target on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $50.71.

Read Our Latest Analysis on Genpact

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines